Physician Administered Drugs: Prior Authorization Requirements
Effective July 1, 2025, Mississippi Medicaid will require prior authorization for 10 new physician-administered drugs (PADs) including aflibercept, olanzapine long-acting, risperidone, inclisiran, vutrisiran, patisiran, eptinezumab, viltolarsen, tezepelumab, and crizanlizumab. Additionally, pemetrexed (J9305) will no longer require prior authorization. Telligen handles all authorization requests for FFS Medicaid beneficiaries.